These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37181705)
1. Diversity and inclusion in clinical trials: Evolution throughout the development of an mRNA COVID-19 vaccine. Hill J; Montross D; Ivarsson M Front Public Health; 2023; 11():1113003. PubMed ID: 37181705 [TBL] [Abstract][Full Text] [Related]
2. Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora. Xu Q; McMann TJ; Li J; Wenzel C; Mackey TK Trials; 2023 Dec; 24(1):790. PubMed ID: 38053216 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
4. Evaluating enrollment and representation in COVID-19 and HIV vaccine clinical trials. Lezo Ramirez D; Koleske E; Ometoruwa O; Park Chang JB; Kanwal U; Morreale N; Avila Paz AA; Tong A; Baden LR; Sherman AC; Walsh SR Front Public Health; 2024; 12():1411970. PubMed ID: 39131572 [TBL] [Abstract][Full Text] [Related]
5. Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies. Hussain B; Latif A; Timmons S; Nkhoma K; Nellums LB Vaccine; 2022 May; 40(25):3413-3432. PubMed ID: 35534309 [TBL] [Abstract][Full Text] [Related]
6. Exploring the inclusion of under-served groups in trials methodology research: an example from ethnic minority populations' views on deferred consent. Raven-Gregg T; Shepherd V Trials; 2021 Sep; 22(1):589. PubMed ID: 34479612 [TBL] [Abstract][Full Text] [Related]
7. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives. Hunter CM; Chou WS; Webb Hooper M Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616 [TBL] [Abstract][Full Text] [Related]
8. Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine. Hyer RN Cancer J; 2022 Mar-Apr 01; 28(2):146-150. PubMed ID: 35333501 [TBL] [Abstract][Full Text] [Related]
9. No Populations Left Behind: Vaccine Hesitancy and Equitable Diffusion of Effective COVID-19 Vaccines. Webb Hooper M; Nápoles AM; Pérez-Stable EJ J Gen Intern Med; 2021 Jul; 36(7):2130-2133. PubMed ID: 33754319 [TBL] [Abstract][Full Text] [Related]
10. A community-partnered approach for diversity in COVID-19 vaccine clinical trials. Castellon-Lopez Y; Landovitz R; Ntekume E; Porter C; Bross R; Hilder R; Lucas-Wright A; Daar ES; Chavez P; Blades C; Carson S; Morris D; Vassar S; Casillas A; Brown A J Clin Transl Sci; 2023; 7(1):e23. PubMed ID: 36714798 [TBL] [Abstract][Full Text] [Related]
11. Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials. Pepperrell T; Rodgers F; Tandon P; Sarsfield K; Pugh-Jones M; Rashid T; Keestra S Glob Health Action; 2021 Jan; 14(1):1892309. PubMed ID: 33627051 [TBL] [Abstract][Full Text] [Related]
12. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
13. Factors Associated With Racial/Ethnic Group-Based Medical Mistrust and Perspectives on COVID-19 Vaccine Trial Participation and Vaccine Uptake in the US. Thompson HS; Manning M; Mitchell J; Kim S; Harper FWK; Cresswell S; Johns K; Pal S; Dowe B; Tariq M; Sayed N; Saigh LM; Rutledge L; Lipscomb C; Lilly JY; Gustine H; Sanders A; Landry M; Marks B JAMA Netw Open; 2021 May; 4(5):e2111629. PubMed ID: 34042990 [TBL] [Abstract][Full Text] [Related]
16. The relationship between trust in federal oversight of vaccine safety and willingness to participate in COVID-19 clinical trials: a repeated measures study of Philadelphia residents (September 2021 - March 2023). Yu H; Bauermeister J; Oyiborhoro U; Morales K; Aryal S; Glanz K; Villarruel A; Bonett S BMC Public Health; 2024 Jul; 24(1):2059. PubMed ID: 39085794 [TBL] [Abstract][Full Text] [Related]
17. Community-based organizations at the front lines of the COVID-19 pandemic: Strategies for building equitable COVID-19 vaccine uptake and distribution. Powell R; Oladipupo B; Evans D; Sidibe T J Emerg Manag; 2024; 22(1):23-30. PubMed ID: 38533697 [TBL] [Abstract][Full Text] [Related]
18. Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19. Iqbal SM; Rosen AM; Edwards D; Bolio A; Larson HJ; Servin M; Rudowitz M; Carfi A; Ceddia F Front Public Health; 2024; 12():1429265. PubMed ID: 39175908 [TBL] [Abstract][Full Text] [Related]
19. A pilot recruitment strategy to enhance ethical and equitable access to Covid-19 pediatric vaccine trials. Muller WJ; Jhaveri R; Heald-Sargent T; Macy ML; Heard-Garris N; Shah S; Paquette E Clin Trials; 2024 Jun; 21(3):390-396. PubMed ID: 38140914 [TBL] [Abstract][Full Text] [Related]
20. Estimation and Comparison of Current and Future Racial/Ethnic Representation in the US Health Care Workforce. Salsberg E; Richwine C; Westergaard S; Portela Martinez M; Oyeyemi T; Vichare A; Chen CP JAMA Netw Open; 2021 Mar; 4(3):e213789. PubMed ID: 33787910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]